Public lists: Pharma Startups (6570)

Vaxent has developed a StepNovA vaccine for Group A streptococcus

Vaxent has developed a StepNovA vaccine for Group A streptococcus

Company (Alive / Active)



Memphis, 37501
Tennessee, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vaxent $0M Dec 1, 2020
See all 15 competitors

Web Traffic


Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Page Views Per Million (PVPM)
Reach Per Million

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vaxent Jobs

jobs by Indeed job


Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.


Company Status Description Investors

VaxInnate Corporation

Cranbury, New Jersey, United States
Dead / InactiveVaxInnate is a privately-held biotechnology company in Cranbury, NJ that is developing a technology platform for use in developing novel and proprietary vaccines. VaxInnate's vaccines focus on infectious diseases, including seasonal and pandemic flu, dengue, and Clostridium difficile. VaxInnate's technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of vaccines. VaxInnate has already generated positive Phase 1, and in some instances Phase...Show allLogin to see details

Lofarma S.p.A.

Alive / ActivennFor more than fifty years, the company have been plotting the route in Allergy medicine. The company have been leading generations of allergists to some of the most discoveries in this science:na vaccine by bronchial route, a vaccine by nasal route, the Methacholine Challenge Test, the Test Dose for foodstuff or additives allergy, and allergens adsorbed on single-use needles.Login to see details
See all 15 competitors


Title Application Date Patent Date Status
(Patent / Application)